Your browser is no longer supported. Please, upgrade your browser.
CERC Cerecor Inc. daily Stock Chart
CERC [NASD]
Cerecor Inc.
Index- P/E4.53 EPS (ttm)0.37 Insider Own24.16% Shs Outstand23.99M Perf Week-3.45%
Market Cap40.30M Forward P/E- EPS next Y-0.87 Insider Trans37.77% Shs Float23.99M Perf Month58.49%
Income13.30M PEG- EPS next Q-0.29 Inst Own66.30% Short Float4.96% Perf Quarter100.00%
Sales25.80M P/S1.56 EPS this Y-53.50% Inst Trans374.88% Short Ratio1.92 Perf Half Y237.35%
Book/sh0.24 P/B7.00 EPS next Y18.70% ROA-213.00% Target Price1.00 Perf Year41.18%
Cash/sh0.23 P/C7.33 EPS next 5Y- ROE- 52W Range0.34 - 2.65 Perf YTD90.82%
Dividend- P/FCF- EPS past 5Y-35.80% ROI-618.50% 52W High-36.60% Beta-
Dividend %- Quick Ratio3.60 Sales past 5Y40.60% Gross Margin- 52W Low393.97% ATR0.25
Employees- Current Ratio3.60 Sales Q/Q-71.40% Oper. Margin-50.40% RSI (14)61.08 Volatility14.63% 18.96%
OptionableNo Debt/Eq0.19 EPS Q/Q66.70% Profit Margin-51.60% Rel Volume0.38 Prev Close1.63
ShortableYes LT Debt/Eq0.00 EarningsNov 06 Payout- Avg Volume619.80K Price1.68
Recom2.00 SMA2024.35% SMA5045.13% SMA200111.84% Volume231,678 Change3.07%
Dec-12-16Downgrade Rodman & Renshaw Buy → Neutral $4 → $1
Apr-13-16Initiated Rodman & Renshaw Buy $15
Dec-09-15Initiated Laidlaw Buy $10
Dec-08-17 10:33AM  Should You Buy Cerecor Inc (CERC) At This PE Ratio? Simply Wall St.
Nov-29-17 07:30AM  This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice ACCESSWIRE +36.36%
Nov-21-17 07:40AM  Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals ACCESSWIRE
Nov-20-17 12:45PM  Is It The Right Time To Buy Cerecor Inc (CERC)? Simply Wall St.
Nov-17-17 10:35AM  Baltimore pharmaceutical company acquiring North Carolina firm for at least $27 million American City Business Journals
08:30AM  Cerecor Announces Leadership Changes Marketwired
08:15AM  Cerecor Acquires TRx Pharmaceuticals Marketwired
08:02AM  Best Undervalued Stock Picks Simply Wall St.
Nov-09-17 11:45AM  CERC: With An Infusion of Non-dilutive Capital, Cerecor Ready to Move the Pipeline Forward Zacks Small Cap Research
Nov-06-17 09:32AM  What does Cerecor Incs (CERC) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
08:15AM  Cerecor Inc. Reports Third Quarter 2017 Financial Results Marketwired
Oct-18-17 08:15AM  Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement Marketwired
Oct-05-17 05:46PM  Dilution Ahead For Cerecor Inc (CERC) Shareholders? Simply Wall St.
Aug-17-17 11:15AM  CERC: Sells CERC-501 for $25 Million; Company Currently Trading Below Cash Value Zacks Small Cap Research
Aug-16-17 01:22PM  What Shareholders Should Make of the Johnson & Johnson-Cerecor Situation GuruFocus.com
10:44AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-14-17 08:04AM  Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Marketwired
08:02AM  Cerecor Inc. Reports Second Quarter 2017 Financial Results Marketwired
08:00AM  Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc. Marketwired
May-30-17 08:30AM  Cerecor to present at the American Society for Clinical Psychopharmacology Conference Marketwired -10.71%
May-15-17 08:30AM  Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors Marketwired
May-10-17 02:00PM  CERC: Encouraging Results from Proof-of-Concept Study of CERC-501 in MDD Zacks Small Cap Research -6.09%
May-09-17 08:30AM  Cerecor Inc. Reports First Quarter 2017 Financial Results Marketwired +13.87%
May-01-17 08:30AM  Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression Marketwired +20.50%
Apr-28-17 08:30AM  Cerecor Inc. Closes $5.0 Million Private Placement Marketwired -16.57%
Mar-21-17 03:00PM  CERC: Ready to Move Ahead With Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research -8.11%
Mar-18-17 01:04PM  CERECOR INC. Financials
Mar-14-17 01:22PM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -10.00%
09:37AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Marketwired
Mar-13-17 05:25PM  CERECOR INC. Files SEC form 8-K, Change in Directors or Principal Officers -24.99%
Mar-02-17 04:39PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Feb-16-17 01:34PM  These 5 Stocks Under $10 Could Explode Higher
Feb-07-17 09:32AM  Cerecor Engages SunTrust Robinson Humphrey to Assist with Review of Strategic Alternatives Marketwired
Jan-30-17 04:34PM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -6.52%
Jan-27-17 04:26PM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits +5.75%
04:20PM  Cerecor Announces At-the-Market Equity Offering Program Marketwired
Jan-20-17 04:05PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Dec-12-16 07:12AM  Cerecor downgraded by Rodman & Renshaw
Dec-06-16 04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) Investopedia -15.79%
04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) at Investopedia
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining Insider Monkey
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining at Insider Monkey
Dec-05-16 03:00PM  CERC: CERC-501 Not Successful in Nicotine Withdrawal; Preparing for Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research -13.14%
11:51AM  Ciao, euro! Global markets gird for the next wave of global populism at MarketWatch
08:16AM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:14AM  Cerecor Inc. shares drop 37% after midstage trial failure at MarketWatch
08:00AM  Cerecor Announces Top-Line Results from CERC-501 Phase 2 Study for Nicotine Withdrawal Marketwired
Dec-01-16 12:45PM  Cerecor Depression Drug Fails Phase 2 Trial (CERC) Investopedia
12:45PM  Cerecor Depression Drug Fails Phase 2 Trial (CERC) at Investopedia
Nov-30-16 12:30PM  CERC: CERC-301 Fails to Show Benefit in MDD in Phase 2 Clinical Trial; Attention Now Turns to CERC-501 -55.93%
Nov-29-16 04:10PM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.63%
04:01PM  Cerecor Reports Top-Line Data from CERC-301 Phase 2 Study for Major Depressive Disorder Marketwired
Nov-11-16 01:00PM  CERC: Results from Phase 2 Study of CERC-301 in Major Depressive Disorder to be Announced in November 2016
Nov-08-16 10:53AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:16AM  Cerecor Inc. Reports Third Quarter 2016 Financial Results Marketwired
Nov-07-16 02:35PM  Discovery of Cerecor Drug Candidate CERC-611 (LY3130481) Published in Nature Medicine Marketwired +9.94%
Oct-24-16 09:59AM  What To Watch From The Upcoming Cerecor Inc (CERC) Release at Insider Monkey
Oct-21-16 08:30AM  Why Traders Are Buzzing About Qualcomm, NXP, Alkermes, Cerecor, and More at Insider Monkey +22.09%
Oct-10-16 09:10AM  Cerecor to Present at the 15th Annual BIO Investor Forum in San Francisco on October 18th, 2016 Business Wire
Sep-29-16 11:00AM  CERC: Acquires Rights to Anti-Epilepsy Drug
Sep-26-16 04:19PM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09:10AM  Cerecor Announces Acquisition of TARP-8-AMPA Receptor Antagonist (CERC-611) from Lilly Business Wire
Sep-22-16 12:00PM  CERC: Multiple Catalysts Upcoming in 4Q16
Sep-21-16 02:23PM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits +8.47%
09:10AM  Cerecor Announces Completion of Enrollment in Phase 2 Clinical Trial with CERC-301 as an Oral, Adjunctive Treatment of Major Depressive Disorder Business Wire
Sep-12-16 09:35AM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
09:10AM  Cerecor Enters Into a $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC Business Wire
Sep-06-16 10:57AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Announces Last Patient Enrolled in Phase 2 Clinical Trial with CERC-501 for Smoking Cessation Business Wire
Sep-01-16 09:10AM  Cerecor to Present at 23rd Annual NewsMakers in the Biotech Industry Conference in New York City, September 9, 2016 Business Wire
Aug-29-16 10:46AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Announces Initiation of Second CERC-501 Phase 2 Clinical Trial in Smokers Business Wire
Aug-23-16 03:30PM  CERC: Results From Phase 2 Clinical Trial of CERC-501 to be Reported in 4Q16
Aug-22-16 09:10AM  Cerecor to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016 Business Wire
Aug-15-16 09:59AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Reports Second Quarter 2016 Financial Results Business Wire
Jul-29-16 09:28AM  These 5 Stocks Are Poised for Breakouts +43.39%
Jul-25-16 09:10AM  Cerecor Announces Research Grant from the Department of Defense to Study CERC-501 in Animal Models for Co-Morbid Post-Traumatic Stress Disorder and Alcohol Use Disorder Business Wire +5.15%
Jul-20-16 12:24PM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:52AM  Cerecor Announces $1.0 Million Research & Development Grant from the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health Business Wire
May-23-16 12:30PM  CERC: Initiating on Cerecor, Inc.; Developing Novel Treatments for Psychiatric Conditions
May-20-16 09:22AM  CERECOR INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securi -6.69%
May-16-16 11:23AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Reports First Quarter 2016 Financial Results Business Wire
Apr-11-16 11:55AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Announces $1.0 Million Research & Development Grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health Business Wire
Mar-23-16 09:32AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 at noodls
09:27AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 Business Wire
Mar-17-16 09:00AM  Laidlaw & Co. Analyst Jim Molloy Interviewed by The Life Sciences Report Marketwired
Mar-08-16 09:10AM  Cerecor Inc. to Present at the Roth Conference on March 16th Business Wire +11.34%
Feb-22-16 09:10AM  Cerecor to Host R&D Day in New York City on March 1, 2016 Business Wire
Feb-02-16 04:55PM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Announces Initiation of Phase 2 Clinical Trial With CERC-501 for Smoking Cessation Business Wire
Feb-01-16 09:31AM  Cerecor Inc. to Present at the BIO CEO & Investor Conference in New York City at noodls -7.73%
09:10AM  Cerecor Inc. to Present at the BIO CEO & Investor Conference in New York City Business Wire
Jan-19-16 11:28AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Announces Publication Describing Antidepressant Activity of CERC-301 in Preclinical Model Business Wire
Jan-12-16 09:10AM  Cerecor Inc. Appoints Thomas Aasen to Board of Directors Business Wire -7.02%
08:08AM  CERECOR INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State
Cerecor, Inc. (Cerecor) is a United States-based biopharmaceutical company. The Company is developing treatments for patients suffering from nervous system disorders. CERC-301 is a potent and selective NR2B antagonist. Cerecor specializes in developing drugs to treat neuropsychological disorders, such as anxiety and depression. Cerecor is focused on translational medicine. It is focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moscato Robert Jr.COODec 04Buy1.772855042,592,743Dec 07 07:15 PM
ARMISTICE CAPITAL, LLCDirectorNov 24Buy1.2010,00011,98016,050,000Nov 24 03:20 PM
ARMISTICE CAPITAL, LLCDirectorNov 22Buy1.2035,20042,21016,040,000Nov 24 03:20 PM
ARMISTICE CAPITAL, LLCDirectorOct 16Buy1.084,8005,17416,004,800Oct 18 05:12 PM
ARMISTICE CAPITAL, LLCDirectorSep 29Buy0.876,8835,98616,000,000Oct 03 06:02 PM
ARMISTICE CAPITAL, LLCDirectorSep 28Buy0.8430025115,993,117Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 27Buy0.811008115,992,817Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 26Buy0.8013,55210,77415,992,717Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 22Buy0.7812,3009,64115,979,165Sep 25 05:27 PM
ARMISTICE CAPITAL, LLCDirectorSep 21Buy0.792,3601,85315,966,865Sep 25 05:27 PM
ARMISTICE CAPITAL, LLCDirectorSep 20Buy0.7615,25011,61015,964,505Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 19Buy0.7430,11922,42915,949,255Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 18Buy0.786,0004,66715,919,136Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 08Buy0.752,0601,55115,913,136Sep 08 05:26 PM
ARMISTICE CAPITAL, LLCDirectorSep 06Buy0.742,2391,64715,911,076Sep 08 05:26 PM
ARMISTICE CAPITAL, LLCDirectorSep 01Buy0.7313,86710,18815,908,837Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 31Buy0.7725,10019,31215,894,970Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 30Buy0.7451237715,869,870Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 29Buy0.7250,00035,79515,869,358Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 28Buy0.7325,32118,37515,819,358Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 25Buy0.7538,32828,89215,794,037Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 24Buy0.7039,88827,88615,755,709Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 24Buy0.7019,94413,94315,755,709Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 23Buy0.621,8001,11315,735,765Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 23Buy0.6290055715,735,765Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 22Buy0.6238,60223,79015,734,865Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 22Buy0.6219,30111,89515,734,865Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 21Buy0.6131,12819,06915,715,564Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 21Buy0.6115,5649,53515,715,564Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 18Buy0.6163,39638,61515,700,000Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 18Buy0.6131,69819,30715,700,000Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 17Buy0.5952,00430,49015,668,302Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 17Buy0.5926,00215,24515,668,302Aug 21 06:02 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 16Buy0.58153,60089,08815,642,300Aug 16 05:13 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 16Buy0.5876,80044,54415,642,300Aug 16 05:13 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 15Buy0.58131,00075,98015,565,500Aug 16 05:13 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 15Buy0.5865,50037,99015,565,500Aug 16 05:13 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 14Buy0.64351,552224,99315,500,000Aug 16 05:13 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 14Buy0.64175,776112,49715,500,000Aug 16 05:13 PM
ARMISTICE CAPITAL, LLCDirectorMay 19Buy0.6348,44830,5223,384,224May 23 10:22 AM
ARMISTICE CAPITAL, LLCDirectorMay 19Buy0.6324,22415,2613,384,224May 23 10:22 AM
ARMISTICE CAPITAL, LLC10% OwnerMay 11Buy0.74172,244127,4613,360,000May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 11Buy0.7486,12263,7303,360,000May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 10Buy0.7955,63843,9543,273,878May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 10Buy0.7927,81921,9773,273,878May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 09Buy0.6672,11847,5983,246,059May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 09Buy0.6636,05923,7993,246,059May 11 05:04 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 08Buy0.65100,00265,0013,210,000May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 08Buy0.6550,00132,5013,210,000May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 05Buy0.6131,59619,2743,159,999May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 05Buy0.6315,7989,9533,159,999May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 04Buy0.6356,82635,8003,144,201May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 04Buy0.6328,41317,9003,144,201May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 03Buy0.55136,71875,1953,115,788May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 03Buy0.5568,35937,5973,115,788May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 02Buy0.53292,190154,8613,047,429May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 02Buy0.53146,09577,4303,047,429May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 01Buy0.50211,240105,6202,901,334May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerMay 01Buy0.50105,62052,8102,901,334May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerApr 28Buy0.44900,000396,0002,795,714May 09 02:21 PM
ARMISTICE CAPITAL, LLC10% OwnerApr 28Buy0.44450,000198,0002,795,714May 09 02:21 PM